Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
HKEX:3347
Holding HK:3347?
Track your performance easily
3347 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$22.10 - HK$58.80
Previous CloseHK$37.85
Volume3.29M
Average Volume (3M)2.87M
Market Cap
HK$52.61B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)14.7
Beta1.84
Next Earnings
Mar 31, 2025EPS Estimate
HK$0.61Last Dividend Ex-Date
Jun 07, 2024Dividend Yield1.7%
Share Statistics
EPS (TTM)1.20
Shares OutstandingN/A
10 Day Avg. Volume3,256,498
30 Day Avg. Volume2,873,556
Standard Deviation0.16
R-Squared0.42
Alpha-0.00957
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)8.19
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$40.99Price Target Upside8.30% Upside
Rating ConsensusHold
Number of Analyst Covering4
Hangzhou Tigermed Consulting Co., Ltd. Class H News
PremiumCompany Announcements
Hangzhou Tigermed’s 2024 Q3 Report Highlights
PremiumCompany Announcements
Hangzhou Tigermed Sets Board Meeting for Q3 Report
PremiumCompany Announcements
Tigermed’s EGM Concludes with Key Resolutions Passed
PremiumCompany Announcements
Tigermed Schedules EGM for Major Corporate UpdatesPremiumCompany Announcements
Tigermed Reallocates IPO Funds for Expansion and Tech
PremiumCompany Announcements
Tigermed Announces Key Organizational AmendmentsPremiumCompany Announcements
Tigermed Reports Decreased Profits Amid Industry RecoveryOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
6.33% Mutual Funds
― Other Institutional Investors
90.92% Public Companies and
Individual Investors
3347 FAQ
What was Hangzhou Tigermed Consulting Co., Ltd. Class H’s price range in the past 12 months?
Hangzhou Tigermed Consulting Co., Ltd. Class H lowest stock price was HK$22.10 and its highest was HK$58.80 in the past 12 months.
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s market cap?
Currently, no data Available
When is Hangzhou Tigermed Consulting Co., Ltd. Class H’s upcoming earnings report date?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s upcoming earnings report date is Mar 31, 2025 which is in 141 days.
How were Hangzhou Tigermed Consulting Co., Ltd. Class H’s earnings last quarter?
Hangzhou Tigermed Consulting Co., Ltd. Class H released its earnings results on Oct 29, 2024. The company reported HK$0.404 earnings per share for the quarter, missing the consensus estimate of HK$0.59 by -HK$0.186.
Is Hangzhou Tigermed Consulting Co., Ltd. Class H overvalued?
According to Wall Street analysts Hangzhou Tigermed Consulting Co., Ltd. Class H’s price is currently Undervalued.
Does Hangzhou Tigermed Consulting Co., Ltd. Class H pay dividends?
Hangzhou Tigermed Consulting Co., Ltd. Class H pays a Annually dividend of HK$0.62 which represents an annual dividend yield of 1.7%. See more information on Hangzhou Tigermed Consulting Co., Ltd. Class H dividends here
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s EPS estimate?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s EPS estimate is HK$0.61.
How many shares outstanding does Hangzhou Tigermed Consulting Co., Ltd. Class H have?
Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding.
What happened to Hangzhou Tigermed Consulting Co., Ltd. Class H’s price movement after its last earnings report?
Hangzhou Tigermed Consulting Co., Ltd. Class H reported an EPS of HK$0.404 in its last earnings report, missing expectations of HK$0.59. Following the earnings report the stock price went down -5.47%.
Which hedge fund is a major shareholder of Hangzhou Tigermed Consulting Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:3347
---
Hangzhou Tigermed Consulting Co., Ltd. Class H Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co Ltd is a China-based Contract Research Organization. It is engaged in providing professional full clinical trial services. The company's offered services include bioanalytical, medical writing, biostatistics analysis, and medical imaging. The therapeutic areas of the company include Infections, Hematology, Cardiovascular, Endocrinology, Rheumatology, Nephrology, and Central Nervous System (CNS) among others.
---
3347 Stock 12 Month Forecast
Average Price Target
HK$40.99
▲(8.30% Upside)
Technical Analysis
Best Analysts Covering 3347
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
+4.63%
reiterated a buy rating last month
Copying Michael Luo CFA's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.63% per trade.
---